Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 367 of 6351
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control By invitation onlyThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each individual patient. Instead of treating all diabetic patients the same way, the SMS classifies patients into one of seve…
Sponsor: Salah Snouda • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New biologic aims to tackle stubborn high triglycerides
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase 3 trial for adults with severe hypertriglyceridemia whose lipid levels remain uncontrolled under standard Icosapent Ethyl background treatment plus lifestyle management. Eligible participants complete a scr…
Phase 3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Smartphone therapy may ease anxiety for those with disabilities
Symptom relief Not yet recruitingThe purpose of this study is to see if a mobile-delivered mental health program called Toivoa-001, which combines digital cognitive behavioral therapy (CBT) with personal mental health coaching, can effectively reduce anxiety in adults with hearing or mobility disabilities. The s…
Sponsor: Toivoa Inc • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New BTK blocker aims to outsmart drug resistance in elderly CLL patients
Disease control Recruiting nowThis phase II trial studies how well pirtobrutinib works in treating elderly patients with chronic lymphocytic leukemia (CLL). Bruton tyrosine kinase (BTK) inhibitors such as ibrutinib, acalabrutinib, and zanubrutinib work by blocking the action of the BTK protein that signals ca…
Phase 2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Triple-Drug cocktail aims to tackle esophageal cancer that resists standard therapy
Disease control Not yet recruitingImmunotherapy combined with chemotherapy has become the first-line standard of care for advanced esophageal squamous cell carcinoma (ESCC), significantly improving patient survival. However, with the widespread adoption of first-line immunotherapy, most patients eventually develo…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gene-Guided Chemo-Free strategy targets AL amyloidosis
Disease control Not yet recruitingThis study is a prospective, single-center, phase Ib/II clinical trial designed to evaluate the tolerability of sonrotoclax plus dexamethasone in this phase Ib/II umbrella study and to determine the recommended phase II dose (RP2D). It also aims to assess the safety and hematolog…
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
AI tool aims to predict breast cancer drug success, sparing patients unnecessary side effects
Knowledge-focused Not yet recruitingThis study aims to develop an AI-based predictive tool to help clinicians more accurately determine whether breast cancer patients can benefit from HER-2-targeted antibody-drug conjugate (T-DXd) therapy before treatment. While HER-2-targeted ADC drugs have significantly improved …
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Which CDK4/6 drug is easiest to tolerate in early breast cancer?
Disease control Not yet recruitingIn recent years, the successful application of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) has transformed the treatment landscape for HR+/HER2- advanced breast cancer and driven research into their use in adjuvant settings. Large Phase III trials including MONARCH-E and NAT…
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Ancient herbs vs. superbugs: can TCM prevent repeat pneumonia?
Disease control Not yet recruitingThis is a multicenter prospective observational cohort study of hospitalized patients with multidrug-resistant bacterial pneumonia. The study will compare patients who receive systemic traditional Chinese medicine treatment during routine clinical care with those who do not recei…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a common cholesterol drug shield the heart after lung surgery?
Prevention Recruiting nowThe goal of this clinical trial is to learn whether short-term treatment with atorvastatin can prevent new abnormal rapid heart rhythms after lung surgery in adults aged 60 years or older who are scheduled to have a lung segment or lung lobe removed. The study will also evaluate …
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Prevention
Last updated Jul 30, 2026 00:00 UTC
-
Can a special PET scan spot hidden prostate cancer after focal therapy?
Diagnosis Not yet recruitingTo determine the effectiveness of Posluma PET Scan for monitoring prostate cancer patients after targeted treatment, including how accurately it can detect any remaining or returning cancer after about 12 months post-treatment.
Phase 2 • Sponsor: Aditya Bagrodia • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Can an experimental pill boost chemotherapy's power against stubborn uterine cancer?
Disease control Not yet recruitingThe purpose of this study is to evaluate whether treatment with the investigational drug OK-1 in combination with paclitaxel can reduce tumor burden in patients with advanced or recurrent endometrial cancer (A/R-EC).
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could popular opinion leaders be the key to HIV prevention?
Prevention Not yet recruitingThe Community Popular Opinion Leader (CPOL) is an intervention dveloped in the United States which identifies, trains, and enlists key opinion leaders within communities to deliver messages to peers and help link them to services. This project involves testing the feasibility and…
Sponsor: Africa Health Research Institute • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Can a modified stomach bypass speed up recovery in advanced gastric cancer?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether stomach-partitioning gastrojejunostomy (SPGJ) more effectively reduces postoperative delayed gastric emptying (DGE) compared to conventional gastrojejunostomy (CGJ) in patients with unresectable stage IV gastric cancer accomp…
Sponsor: Gyeongsang National University Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Bone scans may reveal how breast cancer subtypes spread
Knowledge-focused Not yet recruitingThe goal of this observational study is to evaluate the association between different molecular subtypes of breast cancer and their specific patterns of skeletal metastases on Technetium-99m MDP bone scintigraphy. The study will include adult male and female patients aged 18 to …
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a rare mutation that blocks pain reveal new painkiller targets?
Knowledge-focused Not yet recruitingCongenital insensitivity to pain (CIP) comprises a group of rare genetic disorders caused by mutations in genes essential for pain sensing in humans. Among these, Marsili syndrome is caused by a dominant point mutation in the transcription factor ZFHX2, and it is characterized by…
Sponsor: Aalborg University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a Blood-Derived patch reduce complications in penile surgery?
Disease control Not yet recruitingHypospadias is an anomaly characterized by an ectopic ventral urethral meatus, and an incomplete or hooded prepuce. Its incidence is estimated at 1 in 200-300 live male births, with variations across populations and severity types. Successful hypospadias repair depends largely o…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new injection clear psoriasis when other biologics fail?
Disease control Not yet recruitingThis study is a randomized, double-blind, multicenter, dose-parallel-controlled phase II clinical trial. The study consists of three stages: a 4-week screening period, a 52-week treatment period, and a 12-week follow-up period. For the qualified participants screened, using body…
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a cold snare match heat for polyp removal?
Disease control Not yet recruitingThis multicenter, prospective, randomized, non-inferiority trial aimed to compare the efficacy and safety of cold snare endoscopic mucosal resection (CS-EMR) and hot snare endoscopic mucosal resection (HS-EMR) for resection of intermediate-size (10-20 mm) flat nonpedunculated col…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a Dual-Pronged antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis is an open-label, multicenter, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 Bispecific Antibody Injection in patients with locally advanced or metastatic head and neck tumors a…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC